Drs Kathy Miller and Francisco J. Esteva discuss testing and therapeutic options for the new classification of HER2-ultra-low breast cancer.

New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...

A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...

The new HER2-low category is exposing the limitations of IHC testing, challenging pathologists, and has oncologists ...

Nov 26 (Reuters) - Ratings agency Moody's said on Tuesday that it had cut the outlook on the ratings of seven Adani entities to 'negative' from 'stable,' citing the U.S. indictment of Chairman ...

Speaking to LBC's Nick Ferrari at Breakfast, Fuse said that Band Aid had cost Africa trillions over the years, with the continent being seen as "high risk" as a result of the negative imagery. It ...

State Key Laboratory of Biochemical Engineering, Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China ...

In Azerbaijan, site of the COP29 climate talks and a petrostate, people aren’t only proud of their oil. They swear by its health benefits and visit resorts to soak in it. By Anton Troianovski ...